Factors associated with medication adherence among people with diabetes mellitus in poor urban areas of Cambodia: A cross-sectional study


Autoři: Akiyo Nonogaki aff001;  Hen Heang aff002;  Siyan Yi aff003;  Maurits van Pelt aff002;  Hiroko Yamashina aff006;  Chie Taniguchi aff007;  Tomoko Nishida aff008;  Hisataka Sakakibara aff009
Působiště autorů: Department of Nursing, Graduate School of Medicine, Nagoya University, Nagoya, Aichi, Japan aff001;  MoPoTsyo Patient Information Centre, Phnom Penh, Cambodia aff002;  KHANA Center for Population Health Research, Phnom Penh, Cambodia aff003;  Saw Swee Hock School of Public Health, National University of Singapore and National University Health System, Singapore, Singapore aff004;  Center for Global Health Research, Touro University California, Vallejo, CA, United States of America aff005;  Faculty of Health Sciences, Hokkaido University, Sapporo, Hokkaido, Japan aff006;  College of Nursing, Aichi Medical University, Nagakute, Aichi, Japan aff007;  Department of Nursing, Sugiyama Jogakuen University, Nagoya, Aichi, Japan aff008;  School of Nursing, Ichinomiya Kenshin College, Ichinomiya, Aichi, Japan aff009;  Nagoya University, Nagoya, Aichi, Japan aff010
Vyšlo v časopise: PLoS ONE 14(11)
Kategorie: Research Article
doi: 10.1371/journal.pone.0225000

Souhrn

Background

In Cambodia, the age-standardized prevalence of diabetes mellitus has increased in both men and women. The main objective of this study was to identify factors associated with diabetes medication adherence among people with diabetes mellitus in poor urban areas of Phnom Penh, Cambodia.

Methods

A cross-sectional study was conducted in 2017 using a structured questionnaire for face-to-face interviews by trained interviewers. The participants were people with diabetes mellitus who were the active members of a peer educator network, lived in poor urban areas of Phnom Penh, and attended weekly educational sessions during the survey period. Diabetes medication adherence was measured using four items of modified Morisky Medication Adherence Scale. Participants were classified into two groups based on their adherence score: 0 (high adherence) and from 1 to 4 (medium or low adherence). Sociodemographic characteristics; medical history; accessibility to health services; and knowledge, attitude, and practices related to diabetes mellitus were examined. A multiple logistic regression analysis was conducted adjusting for sex, age, marital status, and education levels.

Results

Data from 773 people with diabetes were included in the analyses. Of the total, 49.3% had a high level of diabetes medication adherence. A high level of adherence was associated with higher family income (≥50 USD per month) (adjusted odds ratio [AOR] = 5.00, 95% confidence interval [CI] = 2.25–11.08), absence of diabetes mellitus-related complications (AOR = 1.66, 95% CI = 1.19–2.32), use of health services more than once per month (AOR = 2.87, 95% CI = 1.64–5.04), following special diet for diabetes mellitus (AOR = 1.81, 95% CI = 1.17–2.81), and absence of alcohol consumption (AOR = 13.67, 95% CI = 2.86–65.34).

Conclusions

High diabetes medication adherence was associated with better family economic conditions, absence of diabetes mellitus-related complications, and healthy behaviors. It would be crucial to improve affordable access to regular follow-ups including promotion of healthy behaviors through health education and control of diabetes mellitus-related complications.

Klíčová slova:

Alcohol consumption – Blood pressure – Blood sugar – Diet – Health education and awareness – Medical education – Socioeconomic aspects of health


Zdroje

1. World Health Organization Western Pacific Region. Noncommunicable disease and poverty. The need for pro-poor strategies in the Western Pacific Region: a review. Manila: World Health Organization, Regional Office for the Western Pacific. 2006. Available from: http://www.wpro.who.int/publications/docs/poverty_ncd.pdf?ua = 1. Cited 30 May 2018.

2. Maryam B, Bart J, Chean RM, Kristine N, Wim VD, Bruno D. Access to Treatment for Diabetes and Hypertension in Rural Cambodia: Performance of Existing Social Health Protection Schemes. PLOS ONE. 2016 Jan 27;11(1):e0146147. doi: 10.1371/journal.pone.0146147 26815916

3. Mannava P, Abdullah A, James C, Dodd R, Annear PL. Health System and Noncommunicable Diseases in the Asia-Pacific Region: A Review of the Published Literature. Asia Pac J Public Health. 2015 Mar; 27(2):NP1–19. doi: 10.1177/1010539513500336 24097936

4. Institute for Health Metrics and Evaluation. Global Burden of Disease Compare. Washington: University of Washington. 2018. Available from: https://vizhub.healthdata.org/gbd-compare/. Cited 18 September 2019.

5. International Diabetes Federation (IDF). IDF Diabetes atlas eighth edition 2017. Brussels: International Diabetes Federation. 2017. Available from: http://diabetesatlas.org/resources/2017-atlas.html. Cited 15 September 2018.

6. World Health Organization. Diabetes Programme Country and regional data on diabetes. Geneva: World Health Organization. 2018. Available from: http://www.who.int/diabetes/facts/world_figures/en/index6.html. Cited 13 March 2018.

7. Dugee O, Sophal O, Enkhtuya P, Manju R, Brian SB. Individual-based primary prevention of cardiovascular disease in Cambodia and Mongolia: early identification and management of hypertension and diabetes mellitus. BMC Public Health. 2012 Apr 2;12:254. doi: 10.1186/1471-2458-12-254 22471424

8. Ir P, Men C, Lucas H, Meessen B, Decoster K, Bloom G, et al. Self-Reported Serious Illnesses in Rural Cambodia: A Cross-Sectional Survey. PLOS ONE. 2010;5(6):e10930. doi: 10.1371/journal.pone.0010930 20532180

9. Hilary K, Lim K, Serey S, Touch K, Gojka R, Michel P. Diabetes and associated disorders in Cambodia: two epidemiological surveys. Lancet. 2005 Nov 5;366(9497):1633–9. doi: 10.1016/S0140-6736(05)67662-3 16271644

10. Marie-Eve R, Petros I, Tony R, Say C, Lim K, Gemma A, et al. Treating 4,000 diabetic patients in Cambodia, a high-prevalence but resource-limited setting; a 5-year study. BMC Med. 2009;7:33. doi: 10.1186/1741-7015-7-33 19602220

11. Oum S, Prak PR, Khuon EM, Mey V, Aim S, Bounchan Y, et al. Prevalence of non-communicable disease risk factors in Cambodia STEPS Survey Country Report, September 2010. Phnom Penh: the University of Health Sciences, the Preventive Medicine Department of the Ministry of Health. 2010. Available from: http://www.who.int/ncds/surveillance/steps/2010_STEPS_Report_Cambodia.pdf. Cited 30 May 2018.

12. International Diabetes Federation (IDF). IDF Diabetes atlas seventh edition 2015. Brussels: International Diabetes Federation. 2015. Available from: https://www.idf.org/e-library/epidemiology-research/diabetes-atlas/13-diabetes-atlas-seventh-edition.html. Cited 30 May 2018.

13. World Health Organization. Adherence to long-term therapies: evidence for action. Geneva: World Health Organization. 2003. Available from: http://www.who.int/chp/knowledge/publications/adherence_full_report.pdf. Cited 26 November 2017.

14. Beena J, Jimmy J. Patient Medication Adherence: Measures in Daily Practice. Oman Med J. 2011;26(3):155–159. doi: 10.5001/omj.2011.38 22043406

15. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005 Aug 4;353(5):487–97. doi: 10.1056/NEJMra050100 16079372

16. Rajesh B, Rukmini R, Fabian TC, Sally AH, Frederick TM, Roger TA. Predictors of Medication Adherence and Associated Health Care Costs in an Older Population with Type 2 Diabetes Mellitus: A Longitudinal Cohort Study. Clin Ther. 2003;25:11.

17. Zahra Y, Reza P, Mohammad RA, Nastaran A, Leila R, Mohammad YRP. Assessment of Self-Care Practice and Its Associated Factors among Diabetic Patients in Urban Area of Urmia, Northwest of Iran. J Res Health Sci. 2011 Jun 13;11(1):33–8. 22911945

18. Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. 1986 Jan;24(1):67–74. doi: 10.1097/00005650-198601000-00007 3945130

19. Elsous A, Radwan M, Al-Sharif H, Abu Mustafa A. Medications Adherence and Associated Factors among Patients with Type 2 Diabetes Mellitus in the Gaza Strip, Palestine. Front Endocrinol. 2017. 8:100. doi: 10.3389/fendo.2017.00100 28649231

20. Luis-Emilio GP, Maria A, Tatiana D, Vicente GG, Domingo OB. Adherence to Therapies in Patients with Type 2 Diabetes. Diabetes Therapy. 2013;4:175–194 doi: 10.1007/s13300-013-0034-y 23990497

21. United Nations Department of Economic and Social Affairs. Economic Analysis Least Developed Country Category: Cambodia Profile. New York: United Nations. 2018. Available from: https://www.un.org/development/desa/dpad/least-developed-country-category-cambodia.html. Cited 12 October 2019.

22. Steffen F Anika Z. Costing of diabetes mellitus type II in Cambodia. Health Econ Rev. 2014 Dec;4(1):24. doi: 10.1186/s13561-014-0024-4 26208925

23. Van Pelt M. Peer Education Networks for people with diabetes mellitus and/or high blood pressure in Cambodia “Healing a Market for Health” 2005–2010. Phnom Penh: MoPoTsyo Patient Information Centre. 2011. Available from: http://www.who.int/alliance-hpsr/projects/alliancehpsr_atm_chronicdiseases_cambodia_.pdf. Cited 10 March 2018.

24. Natalie E. Evaluation of a peer-education program for diabetes and hypertension in rural Cambodia. M. Thesis, Ghent: Ghent University. 2011. Available from: https://lib.ugent.be/fulltxt/RUG01/001/787/875/RUG01-001787875_2012_0001_AC.pdf. Cited 30 May 2018.

25. Ministry of Health, Kingdom of Cambodia. National Strategic Plan for the Prevention and Control of Noncommunicable Diseases Cardiovascular Disease, Cancer, Chronic Respiratory Disease and Diabetes 2013–2020. Phnom Penh: Ministry of Health, Kingdom of Cambodia. Manila: World Health Organization, Regional Office for the Western Pacific. 2013. Available from: http://www.iccp-portal.org/system/files/plans/KHM_B3_NSP-NCD%202013-2020_Final%20approved.pdf. Cited 30 May 2018.

26. Taniguchi D, LoGerfo J, Van Pelt M, Mielcarek B, Huster K, Haider M, et al. Evaluation of a multi-faceted diabetes care program including community-based peer educators in Takeo province, Cambodia, 2007–2013. PLOS ONE. 2017;12(9): e0181582. doi: 10.1371/journal.pone.0181582 28945753

27. Josefien VO, Natalie E, Van Pelt M, Heang H, Jeroen DM, François S, et al. Patient-centred innovation to ensure access to diabetes care in Cambodia: the case of MoPoTsyo. J Pharm Policy Pract. 2016;9:1 doi: 10.1186/s40545-016-0050-1 26798483

28. Xi T, Isha P, Jongwha C. Review of the four item Morisky Medication Adherence Scale (MMAS-4) and eight item Morisky Medication Adherence Scale (MMAS-8). Innov Pharm. 2014;5(3): Article 165.

29. Morisky DE, Ang A, Krousel-Wood M, Ward HJ. Predictive Validity of a Medication Adherence Measure for in an Outpatient Setting. J Clin Hypertens. 2008 May;10(5):348–354. doi: 10.1111/j.1751-7176.2008.07572.x 18453793.

30. Krousel-Wood M, Islam T, Webber LS, Re RS, Morisky DE, Muntner P. New Medication Adherence Scale Versus Pharmacy Fill Rates in Seniors with Hypertension. Am J Manag Care. 2009 Jan;15(1):59–66. 19146365.

31. Morisky DE, DiMatteo MR. Improving the Measurement of Self-Reported Medication Nonadherence: Response to Authors. J Clin Epidemiol. 2011 Mar;64(3):255–263. doi: 10.1016/j.jclinepi.2010.09.002 21144706.

32. Stephanie S, Viet-Thi T, Cecile C, Elodie P, Philippe R. Development and validation of an instrument to access treatment adherence for each individual drug taken by a patient. BMJ Open. 2016. 10;6(5):e010510. doi: 10.1136/bmjopen-2015-010510 27165645

33. Tim E, Stephanie C. Overcoming barriers to health service access: influencing the demand side. Health Policy Plan. 2004 Mar;19(2):69–79. doi: 10.1093/heapol/czh009 14982885

34. CBM Cambodia, Australia project, Takeo Eye Hospital. Knowledge, Attitudes and Practice survey-2010. Takeo Province, Cambodia. June 2011. Final report. Takeo: CBM Cambodia, Australia project, Takeo Eye Hospital. 2011. Available from: http://www.caritascambodia.org/teh/images/tehdocs/research/Takeo_Province_KAP_FINAL_REPORT.pdf. Cited 14 September 2018.

35. World Health Organization. Advocacy, communication and social mobilization for TB control: a guide to developing knowledge, attitude and practice surveys. Geneva: World Health Organization. 2008. Available from: http://apps.who.int/iris/bitstream/handle/10665/43790/9789241596176_eng.pdf;jsessionid=7726D49E9B0885A2BBE0252E8757D6E4?sequence=1. Cited 30 May 2018.

36. MoPoTsyo Patient Information Centre. Report on a Mid-Term Review of MoPoTsyo Patient Information Center’s Diabetes Intervention in 3 urban slums (period July 2005 until December 2006). Phnom Penh: MoPoTsyo Patient Information Centre. 2007. Available from: http://old.MoPoTsyo.org/report1styear20070429.pdf. Cited 30 May 2018.

37. Islam FM, Chakrabarti R, Dirani M, Islam MT, Ormsby G, Wahab M, et al. Knowledge, Attitudes and Practice of Diabetes in Rural Bangladesh. The Bangladesh Population Based Diabetes and Eye Study (BPDES). PLOS ONE. 2014 Oct 14;9(10):e110368. doi: 10.1371/journal.pone.0110368 25313643

38. Alessandro RD, Dugee O, Maximilian DC, Ib CB, Palam E, Janchiv O, et al. Exploring knowledge, attitudes and practices related to diabetes in Mongolia: a national population-based survey. BMC Public Health. 2013;13:236. doi: 10.1186/1471-2458-13-236 23506350

39. Al-Maskari F, El-Sadig M, Al-Kaabi JM, Afandi B, Nagelkerke N, Karin BY. Knowledge, Attitude and Practices of Diabetic Patients in the United Arab Emirates. PLOS ONE. 2013;8(1):e52857. doi: 10.1371/journal.pone.0052857 23341913

40. Darren AD, Nancy DB, Stacey S, Kathleen NL, Michael PP. Literacy and Health Outcomes. A systematic Review of the Literature. J Gen Intern Med. 2004;19:1228–1239. doi: 10.1111/j.1525-1497.2004.40153.x 15610334

41. Lai SY, Yahaya H, Noorizan AA, Ahmed A, Rozina G. A comparison of knowledge of diabetes mellitus between patients with diabetes and health adults: A survey from north Malaysia. Patient Educ Couns. 2007;69:47–54. doi: 10.1016/j.pec.2007.06.017 17720351

42. Rasaq OS, Sannni AM, Odeigah OL, Abdullateef GS, Issa BA, Okesina BS, et al. Adherence to anti-hypertensive medications and associated factors among patients in a Nigerian family practice setting. Int J Med Res Pharm Sci. 2015;2:5.

43. Lee GKY, Wang HHX, Liu KQL, Cheung Y, Morisky DE, Wong MCS. Determinants of Medication Adherence to Antihypertensive Medications among a Chinese Population Using Morisky Medication Adherence Scale. PLOS ONE. 2013;8(4):e62775. doi: 10.1371/journal.pone.0062775 23638143

44. Smita S, Mayur J, Sonali P, Kavita J, Chaitali B. Evaluation of Adherence to Therapy in Patients of Type 2 Diabetes Mellitus. J Young Pharm. 2015;7:4.

45. Iloh GUP, John NO, Njoku PU, Amadi AN, Godswill-Uko EU. Blood Glucose Control and Medication Adherence Among Adult Type 2 Diabetic Nigerians Attending A Primary Care Clinic in Under-resourced Environment of Eastern Nigeria. N Am J Med Sci. 2012 Jul;4(7):310–315. doi: 10.4103/1947-2714.98590 22866268

46. John DP, Todd HW, Michael BP, Dean S. Health Insurance Status, Cost-Related Medication Underuse, and Outcomes Among Diabetes Patients in Three Systems of Care. Med Care. 2004;42(2):102–109. doi: 10.1097/01.mlr.0000108742.26446.17 14734946

47. Clarissa CAA, Heloisa TGF, Carla RDST, Manoel ADS, Maria LZ. Adherence to diabetes mellitus treatment and sociodemographic, clinical and metabolic control variables. Acta Paul Enferm. 2015;28(4):315–22.

48. Bader RJK, Koprulu F, Hassan NAGM, Ali AAA, Elnour AA. Predictors of adherence to antihypertensive medication in northern United Arab Emirates. East Mediterr Health J. 2015;21:5.

49. Sivasankaran P, Mallayasamy S, Nunjundiah A, Bhojraj S. Assessment of impact of medication counseling on patients’ medication knowledge and compliance in an outpatient clinic in South India. Patient Educ Couns. 2004 Jul;54(1):55–60. doi: 10.1016/S0738-3991(03)00193-9 15210260

50. Karlon HJ, Mohsen B Eric GB. Alcohol Consumption and Compliance Among Inner-city Minority Patients With Type 2 Diabetes Mellitus. Arch Fam Med. 2000 Nov-Dec;9(10):964–70. doi: 10.1001/archfami.9.10.964 11115194

51. Chris LB, David HA, Haili S, Emily CW, Daniel RK, Katharine AB. Alcohol Screening Scores and Medication Nonadherence. Ann Intern Med. 2008 Dec 2;149(11):795–804. doi: 10.7326/0003-4819-149-11-200812020-00004 19047026

52. Arthur H, Sarah K, Paul J, Yinghui X, Michael K, Jeanette D. Factors that influence improvement for patients with poorly controlled type 2 diabetes. Diabetes Res Clin Pract. 2006 Dec;74(3):227–32. doi: 10.1016/j.diabres.2006.03.023 16723163

53. Farzana S, Shirin JM, Ferdous A, Md AH, Liaquat A. Non-adherence to self-care practices & medication and health related quality of life among patients with type 2 diabetes: a cross-sectional study. BMC Public Health. 2014 May 7;14:431. doi: 10.1186/1471-2458-14-431 24885315

54. Nur SA, Azuana R, Farida I, Thomas P. Medication adherence in patients with type 2 diabetes mellitus treated at primary health clinics in Malaysia. Patient Prefer Adherence. 2013;7:525–30. doi: 10.2147/PPA.S44698 23814461

55. Ebenezer AA, Adekunle OA, Iyiade AA, Akande OA, Victor OA. Adherence to Antihypertensive Medications and Some of Its Clinical Implications in Patients Seen At a Tertiary Hospital in Nigeria. IOSR-JDMS. 2013;8(4):36–40.


Článek vyšel v časopise

PLOS One


2019 Číslo 11